Onconetix (ONCO) Stock Price
Onconetix Price
Revenue has compounded at 273.4% per year over the past 2 years to 815,371.00 USD. Onconetix's net margin stands at -1,721.0%, up from -63,986.5% several years earlier.
Onconetix stock price
Onconetix business model & stock analysis
Frequently asked questions about Onconetix
6 analysts currently rate the Onconetix stock: 0 recommend buying, 3 holding and 3 selling.
Converted at the current exchange rate, the Onconetix share trades at 0.55 EUR (0.62 USD).
The Onconetix share (ONCO) is listed on 4 stock exchanges, including: NASDAQ (BWV), Frankfurt (J4T.F), München (J4T.MU), Düsseldorf (J4T.DU).
The revenue cannot currently be calculated for Onconetix.
The profit cannot currently be calculated for Onconetix.
The P/E ratio cannot be calculated for Onconetix at the moment.
The P/S cannot be calculated for Onconetix currently.
The Eulerpool Quality Score for Onconetix is 3/10.
The ISIN of Onconetix is US68237Q2030. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Onconetix is A3DGEQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Onconetix is ONCO. The ticker symbol is used to trade Onconetix shares on the stock exchange.
Onconetix stock
Onconetix Peer Group
Onconetix Ticker
All fundamentals and in-depth analysis of Onconetix
Our stock analysis for Onconetix stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Onconetix. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.